Literature DB >> 27430997

[Non-cardiac aspects of aortic stenosis in the elderly: A review].

Baldomero Álvarez-Fernández1, Francesç Formiga2, Manuel de Mora-Martín3, Fernando Calleja4, Ricardo Gómez-Huelgas5.   

Abstract

Aortic stenosis (AS) is the most frequent valve disease in the elderly population Treatment is valve replacement either by open surgery, or in the case of patients at high surgical risk, by TAVI (Transcatheter Aortic Valve Implantation). However, almost 40% of patients who have undergone TAVI show poor health outcomes, either due to death or because their clinical status does not improved. This review examines the non-cardiac aspects of patients with AS, which may help answer three key questions in order to evaluate this condition pre-surgically: 1) Are the symptoms presented by the patient exclusively explained by the AS, or are there other factors or comorbidities that could justify or increase them?, 2) What possibilities for improvement of health status and quality of life has the patient after the valve replacement?, and 3) How can we reduce the risk of a futile valve replacement?
Copyright © 2016 SEGG. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Anciano; Aortic stenosis; Elderly; Estenosis aórtica; Fragilidad; Fragility; Implante valvular aórtico transcatéter; Transcatheter aortic valve implantation

Mesh:

Year:  2016        PMID: 27430997     DOI: 10.1016/j.regg.2016.06.001

Source DB:  PubMed          Journal:  Rev Esp Geriatr Gerontol        ISSN: 0211-139X


  1 in total

1.  Frailty Assessment in a Cohort of Elderly Patients with Severe Symptomatic Aortic Stenosis: Insights from the FRailty Evaluation in Severe Aortic Stenosis (FRESAS) Registry.

Authors:  Pablo Solla-Suárez; Pablo Avanzas; Isaac Pascual; Manuel Bermúdez-Menéndez De La Granda; Marcel Almendarez; Jose M Arche-Coto; Daniel Hernández-Vaquero; Rebeca Lorca; Eva López-Álvarez; Rut Álvarez-Velasco; Carmen Moreno-Planillo; César Morís de la Tassa; José Gutiérrez-Rodríguez
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.